Last reviewed · How we verify
NCT06195163: TRAP
TRAP Study: Testosterone for Androgen Receptor Polymorphism
Phase 4 trial testing Transdermal Gel in Sachet Dosage Form in Fertility Disorders in 100 participants. Not yet recruiting.
30 September 2026
Quick facts
| Lead sponsor | Instituto Bernabeu |
|---|---|
| Phase | Phase 4 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 30 September 2025 |
| Primary completion | 30 September 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Transdermal Gel in Sachet Dosage Form — full drug profile →
- No pretreatment — full drug profile →
Conditions studied
- Fertility Disorders — all drugs for Fertility Disorders →
Sponsor
Instituto Bernabeu — full company profile →
Who can join
Adults 18 to 40, female only, with Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine whether pretreatment with transdermal testosterone increases the number of cumulus-oocyte complexes (COCs) obtained after ovarian stimulation by more than 1.5 in patients with low ovarian reserve and androgen receptor polymorphism undergoing intracytoplasmic sperm injection (ICSI).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06195163
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fertility Disorders
Currently open trials in the same condition.
- NCT07017972 — Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model · recruiting
- NCT06928337 — Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. · recruiting
- NCT06799507 — The Effect of Mindfulness-Based Lifestyle Support Program on Infertile Women · NA · recruiting
- NCT04663971 — Fertility and Pregnancy After Surgery IBD Audit · recruiting
- NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting
Other Instituto Bernabeu trials
Trials by the same sponsor.
- NCT07364526 — Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients · recruiting
- NCT07270081 — Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEID · NA · completed
- NCT05954962 — Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. · Phase 4 · completed
- NCT05815719 — Continuous Double Ovarian Stimulation. · Phase 4 · completed
- NCT05960370 — Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06195163 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Bernabeu
- Last refreshed: 9 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06195163.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing